CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 16 enrolled
Drug / intervention
Lanthanum Carbonate +3 moredrug
Likely dose
Lanthanum Carbonate 1000mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00438932
NCT00438932N/ACompleted
CompareCT.gov

Reduced Phosphate Intake in "Normo-Phosphatemic" Chronic Kidney Disease Patients

Massachusetts General Hospital·interventional·Posted Feb 22, 2007·Updated Sep 27, 2011

In Brief

A clinical study evaluating Lanthanum Carbonate, Low Phosphorus Diet, and 2 other interventions for Chronic Kidney Disease. Completed, enrolled 16 participants across 1 site.

Detailed Summary

The purpose of this study is to learn more about how the kidneys control the blood levels of phosphorus in patients with early chronic kidney disease. The ultimate goal is to use this information to design improved treatment strategies for phosphorus-related problems for the millions of patients with chronic kidney disease.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Kidney Disease
CountriesUnited States
CollaboratorsShire

Timeline

N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedFeb 22, 2007
Enrollment StartJan 1, 2007
Primary CompletionJan 1, 2010
TodayJul 2, 2026
Enrollment to primary: 3 yearsPosted 19.4 years ago

Interventions

Lanthanum Carbonatedrug

Lanthanum carbonate 1000mg 3x/day

Low Phosphorus Dietdietary

Low phosphorus diet will consist of 800 mg of phosphorus per day.

Unrestricted Phosphorus Dietdietary

Unrestricted diet will contain 1550 mg of phosphorus per day - 800 mg of which is dietary and 750mg of Neutraphos (3 packets/day); each packet is 250mg.

Placebodrug

Lanthanum Carbonate placebo given three times a day with meals.